Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms

Journal of Surgical Research

Volumn 79, Issue 2, 1998, Pages 146-153

  Gracia, E ^a,d   Lacleriga A ^b   Monzon M ^a   Leiva, J ^c   Oteiza, C ^c   Amorena, B ^a,e  

^a CSIC   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

^d Exopol S L CEEI Aragón   (Spain)

^e Centro de Investigación y Tecnología Agroalimentaria de Aragón   (Spain)

Author keywords

Antibiotic therapy; Biofilm; Cefuroxime; Rat osteomyelitis; Slime; Staphylococcus aureus; Tobramycin; Vancomycin

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIBIOTIC AGENT; CEFUROXIME; TOBRAMYCIN; VANCOMYCIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BIOFILM; BIOLUMINESCENCE; CONTROLLED STUDY; DRUG EFFICACY; IN VITRO STUDY; IN VIVO STUDY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; OSTEOMYELITIS; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS AUREUS;

EID: 0032190015     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5416     Document Type: Article

References (46)

1. Gristina A. G. Implant failure and the immuno-incompetent fibro-inflammatory zone. Clin. Orthop. Rel. Res. 298:1994;106.
2. Gristina A. G., Hobgood C. D., Webb L. X., Myrvick Q. N. Adhesive colonization of biomaterials and antibiotic resistance. Biomaterials. 8:1987;423.
3. Mayberry-Carson K. J., Tober-Meyer B., Smith J. K., Lambe D. W., Costerton J. W. Bacterial adherence and glycocalyx formation in osteomyelitis experimentally induced withStaphylococcus aureus. Infect. Immun. 43:1984;825.
4. Norden C. W., Budinsky A. Treatment of experimental chronic osteomyelitis due toStaphylococcus aureus. J. Infect. Dis. 161:1990;52.
5. Lasierra, J. M. Influencia de un tallo metálico compacto intramedular sobre un modelo de osteomielitis experimental, University of Zaragoza, Zaragoza, Spain, 1990.
6. Power M. E., Olson M. E., Domingue P. A. G., Costerton J. W. A rat model ofStaphylococcus aureus. J. Med. Microbiol. 33:1990;189.
7. Brandt C. M., Rouse M. S., Tallan B. M., Laue N. W., Wilson W. R., Steckelberg J. M. Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant β-lactamase-producing coagulase-negative staphylococcal experimental endocarditis. Antimicrob. Agents Chemother. 39:1995;1815.
8. Widmer A. F., Frei R., Rajacic Z., Zimmerli W. Correlation betweenin vivoin vitro. J. Infect. Dis. 162:1990;96.
9. Zimmerli W., Frei R., Widmer F., Rajacic Z. Microbiological test to predict treatment in experimental device related infections due toStaphylococcus aureus. J. Antimicrob. Chemother. 33:1994;959.
10. Ward K. H., Olson M. E., Lam K., Costerton J. W. Mechanism of persistent infection associated with peritoneal implants. J. Med. Microbiol. 36:1992;406.
11. Blaser J., Vergeres P., Widmer F., Zimmerli W. In vivoin vitro. Antimicrob. Agents Chemother. 39:1995;1134.
12. Chuard C., Lucet J. C., Rohner P., Herrmann M., Auckenthaler R., Waldvogel F. A., Lew D. P. Resistance ofStaphylococcus aureusin vivo. J. Infect. Dis. 163:1991;1369.
13. Bergamini T. M., Corpus R. A., Brittian K. R., Peyton J. C., Cheadle W. G. The natural history of bacterial biofilm graft infection. J. Surg. Res. 56:1994;393.
14. Pérez Fernández P., Herrera Y., Martínez P., Gómez-Lus M. L., Prieto J. Enhancement of the susceptibility ofStaphylococcus aureus. Exp. Chemother. 41:1995;45.
15. Baselga R., Albizu I., Aguilar B., Iturralde M., Amorena B. Hydrophobicity of ruminant mastitisStaphylococcus aureus. Curr. Microbiol. 25:1992;173.
16. Freeman D. J., Falkiner F. R., Keane C. T. New method for detecting slime production by coagulase negative staphylococci. J. Clin. Pathol. 42:1989;872.
17. Christensen G. D., Simpson W. A., Younger J. J., Baddour L. M., Barret F. F., Melton D. M., Beachey E. H. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: A quantitative model for the adherence of staphylococci to medical device. J. Clin. Microbiol. 22:1985;996.
18. Flecknell P. Anaesthesia and post-operative care of small mammals. In Practice. Sept. 1991;181.
19. Baselga R., Albizu I., de la Cruz M., del Cacho E., Barberán M., Amorena B. Phase variation of slime production inStaphylococcus aureus: Infect. Immun. 61:1993;4857.
20. Anwar H., Strap J. L., Costerton J. W. Establishment of aging biofilms: Possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob. Agents Chemother. 36:1992a;1347.
21. Domingue G., Ellis B., Dasgupta M., Costerton J. W. Testing antimicrobial susceptibilities of adherent bacteria by a method that incorporates guidelines of the National Committee for Clinical Laboratory Standards. J. Clin. Microbiol. 32:1994;2564.
22. National Committee for Clinical Laboratory Standards, NCCLS methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, Vol 2, Villanova, PA, National Committee for Clinical Laboratory Standards, 1990.
23. Morris T. H. Antibiotic therapeutics in laboratory animals. Lab. Anim. 29:1995;16.
24. Lew D. P., Waldvogel F. A. Osteomyelitis. New Engl. J. Med. 336:1997;999.
25. Delaroy Y. D., Messedi N., Grollier G., Grigson B. Kinetics of bactericidal activity of antibiotics measured by luciferin-luciferase assay. J. Biolum. Chemilum. 6:1991;193.
26. Ward D. R., LaRocco K. A., Hopson D. J. Adenosine triphosphate bioluminescent assay to enumerate bacterial numbers on fresh fish. J. Food Protect. 49:1986;647.
27. Cagni A., Chuard Ch., Vaudaux P. E., Schenzel J., Lew D. P. Comparison of sparfloxacin, temafloxacin, and ciprofloxacin for prophylaxis and treatment of experimental foreign-body infection by methicillin-resistantStaphylococcus aureus. Antimicrob. Agents Chemother. 39:1995;1655.
28. Bamberger D. M., Fields M. T., Herndon B. L. Efficacies of various antimicrobial agents in treatment ofStaphylococcus aureusin vitro. Antimicrob. Agents Chemother. 35:1991;2335.
29. Kaarsemaker S., Walenkamp G. H. I. M., Bogaard A. E. J. New model for chronic osteomyelitis withStaphylococcus aureus. Clin. Orthop. Rel. Dis. 339:1997;246.
30. Gracia E., Fernández A., Conchello P., Laclériga A., Paniagua L., Seral F., Amorena B. Adherence ofStaphylococcus aureus. Int. Orthop. 21:1997;46.
31. Monleón E., Pacheco C., Luján L., Bolea R., Luco D., Alabart J. L., Badiola J. J., Amorena B. Effect ofin vitro. Vet. Microbiol. 57:1997;13.
32. Bouchenaki N., Vaudaux P. E., Huggler E., Waldvogel F. A., Lew D. P. Successful single-dose prophylaxis ofStaphylococcus aureus. Antimicrob. Agents Chemother. 34:1990;21.
33. Barth E., Myrvik Q. M., Wagner W., Gristina A. G. In vitroin vivoStaphylococcus aureusStaphylococcus epidermidis. Biomaterials. 10:1989;325.
34. Belmatoug N., Crémieux A.-C., Bleton R., Volk A., Saleh-Mghir A., Grossin M., Garry L., Carbon C. A new model of experimental prosthetic joint infection due to methicillin-resistantSatphylococcus aureus: J. Infect. Dis. 174:1996;414.
35. Anwar H., Strap J. L., Costerton J. W. Eradication of biofilm cells ofStaphylococcus aureus. Can. J. Microbiol. 38:1992b;618.
36. Bergamini T. M., McCurry T. M., Bernard J. D., Hoeg K. L., Corpus R. A., Peyton J. C., Brittain K. R., Cheadle W. G. Antibiotic therapy againstStaphylococcus epidermidis. J. Surg. Res. 60:1996;3.
37. Daschner F. D., Kropec A. Glycopeptides in the treatment of staphylococcal infections. Eur. J. Clin. Microbiol. Infect. Dis. 14:1995;12.
38. Dunne W. M., Mason E. O., Kaplan S. L. Diffusion of rifampin and vancomycin through aStaphylococcus epidermidis. Antimicrob. Agents Chemother. 37:1993;2522.
39. Marrie T. J., Nelligan J., Costerton J. W. A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation. 66:1982;1339.
40. Brown M. R., Allison D. G., Gilbert P. Resistance of bacterial biofilms to antibiotics: A growth-rate related effect. J. Antimicrob. Chemother. 22:1988;777.
41. Dall L., Herndon B. Quantitative assay of glycocalyx produced byviridians. J. Clin. Microbiol. 279:1989;2039.
42. Costerton J. W., Cheng J. K., Geesey G. G., Ladd T. I., Nickel J. C., Dasgupta M., Marrie T. J. Bacterial biofilms in nature and diseases. Annu. Rev. Microbiol. 41:1987;435.
43. Vorachit M., Lam K., Jayanetra P., Costerton J. W. Resistance ofPseudomonas pseudomallei. Antimicrob. Agents Chemother. 37:1993;2000.
44. Faber B. F., Kaplan M. H., Colgston A. Staphylococcus epidermidis. J. Infect. Dis. 161:1990;37.
45. Deighton M. A., Borland R., Capstick J. A. Virulence ofStaphylococcus epidermidis. Epidemiol. Infect. 117:1996;267.
46. Baselga R., Albizu I., Amorena B. Staphylococcus aureus. Vet. Microbiol. 39:1994;195.